Watch Now: Calidi Biotherapeutics and City of Hope announce first patients dosed in a Phase 1 clinical trial
→
Company
Company
About
History
Team
Careers
Medical & Scientific Advisors
Board of Advisors
Our Science
How It Works
Novel Platform
Publications
Medical & Scientific Advisors
Board of Advisors
Our Science
Pipeline
Newsroom
Investors
English
Contact
Publication
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
The Journal of Translational Medicine
March 27, 2019
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more